About

About Calviri, Inc. Calviri is early phase company focused on diagnostics to detect cancer early and vaccines to treat or even prevent cancer. We are completing a 5-year, 800 dog clinical trial that demonstrates efficacy and safety of our broadly preventative cancer vaccine. We will initiate sales of the vaccine in 2025 and initiate human trials. Our diagnostic is able to detect stage 1 tumors with high sensitivity using a completely new platform. We will initiate sales of the dog diagnostic in 2024. Calviri is poised to transform cancer for both dogs and people. About Calviri, Inc. Calviri is early phase company focused on diagnostics to detect cancer early and vaccines to treat or even prevent cancer. We are completing a 5-year, 800 dog clinical trial that demonstrates efficacy and safety of our broadly preventative cancer vaccine. We will initiate sales of the vaccine in 2025 and initiate human trials. Our diagnostic is able to detect stage 1 tumors with high sensitivity using a completely new platform. We will initiate sales of the dog diagnostic in 2024. Calviri is poised to transform cancer for both dogs and people. Calviri’s mission is to End Cancer - Worldwide. We have made the discoveries and invented the technologies that make this mission possible. We will deliver products for stage 1 cancer detection, a vaccine to treat, and ultimately a vaccine to prevent canine cancer.